Cell MedX Corp. (CMXC) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 138 transactions totaling $658.0K, demonstrating a bullish sentiment with $242.5K in net insider flow. The most recent transaction on Dec 29, 2023 involved a transaction of 61,755,148 shares valued at $0.
No significant insider buying has been recorded for CMXC in the recent period.
No significant insider selling has been recorded for CMXC in the recent period.
Based on recent SEC filings, insider sentiment for CMXC is bullish with an Insider Alignment Score of 68/100 and a net flow of $242.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Cell MedX Corp. (CMXC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading CMXC stock, having executed 138 transactions in the past 90 days. The most active insider is Richard Jeffs (Executive), who has made 90 transactions totaling $704.5K.
Get notified when executives and directors at CMXC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | Vahabzadeh Amir | Executive | Award | 61,755,148 | $N/A | $0 | |
| Dec 29, 2023 | Dacosta Joao | Executive | Award | 531,687 | $N/A | $0 | |
| Dec 29, 2023 | Yaretz Dwayne | Executive | Award | 1,214,285 | $N/A | $0 | |
| Dec 29, 2023 | Jeffs Richard | Executive | Purchase | 14,372,285 | $N/A | $0 | |
| Dec 29, 2023 | Jeffs David | Executive | Purchase | 7,500,000 | $N/A | $0 | |
| Dec 29, 2023 | Jeffs David | Executive | Purchase | 7,500,000 | $N/A | $0 | |
| Dec 29, 2023 | Jeffs David | Executive | Award | 73,959,726 | $N/A | $0 | |
| Apr 6, 2022 | S. Hargreaves Bradley | Executive | Sale | 10,000 | $0.15 | $1.5K | |
| Feb 7, 2022 | S. Hargreaves Bradley | Executive | Sale | 300 | $0.18 | $54 | |
| Feb 7, 2022 | S. Hargreaves Bradley | Executive | Sale | 300 | $0.18 | $54 | |
| Feb 4, 2022 | S. Hargreaves Bradley | Executive | Sale | 7,000 | $0.15 | $1.1K | |
| Jan 5, 2022 | S. Hargreaves Bradley | Executive | Sale | 7,500 | $0.15 | $1.1K | |
| Dec 29, 2021 | S. Hargreaves Bradley | Executive | Sale | 5,000 | $0.18 | $900 | |
| Dec 20, 2021 | S. Hargreaves Bradley | Executive | Sale | 5,000 | $18.20 | $91.0K | |
| Dec 15, 2021 | S. Hargreaves Bradley | Executive | Sale | 4,654 | $0.19 | $884 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 3 | $498.4K | 43.1% |
Purchase(P) | 91 | $450.2K | 38.9% |
Sale(S) | 39 | $207.7K | 18.0% |
Award(A) | 4 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at Cell MedX Corp. are accumulating shares at an accelerated pace. With 8 insiders making 138 transactions totaling $450.2K in purchases versus $207.7K in sales, the net buying activity of $242.5K signals strong executive confidence. Richard Jeffs (Executive) leads the buying activity with $704.5K in transactions across all time.